Sarclisa Approved for Treatment of Multiple Myeloma

Alternative Medicine Drug Resistance News

TUESDAY, March 3, 2020 — Sarclisa (isatuximab-irfc) has been approved for the treatment of adults with multiple myeloma in combination with pomalidomide and dexamethasone, the U.S. Food and Drug Administration announced Monday.
Sarclisa, in…

Leave a Reply

Your email address will not be published. Required fields are marked *